» Articles » PMID: 36158286

Primary Pure Large-Cell Neuroendocrine Carcinoma of the Ovary: A Rare Case Report

Overview
Date 2022 Sep 26
PMID 36158286
Authors
Affiliations
Soon will be listed here.
Abstract

Primary pure large-cell neuroendocrine carcinoma is a rare entity with 17 cases reported till now. A 48-year-old, Para6 Live4, postmenopausal woman presented with complaints of pain abdomen, constipation for 6 months, and postmenopausal bleeding for 1 month. On per abdominal examination, an irregular, hard, fixed, and tender mass was felt in the pelvis corresponding to 32 weeks size gravid uterus. Her magnetic resonance imaging findings were suggestive of a large abdominopelvic mass of size 10.2 cm × 12.7 cm × 14.2 cm with inferior extension into the left adnexa and 3.1 cm × 2.2 cm × 2.1 cm right adnexal mass. Debulking surgery was done. The intraoperative findings were of a large abdominopelvic mass adhered to the sigmoid colon and retroperitoneal space. Histopathological and immunohistochemistry findings were suggestive of bilateral large-cell neuroendocrine carcinoma of ovaries with strong positive for Bcl2, CD56, NSE, PR, and P53. The patient was started on tablet etoposide as adjuvant treatment. After 5 months of primary surgery, contrast-enhanced computed tomography of the chest, abdomen, and pelvis revealed recurrence. She succumbed to her illness 6 months after primary surgery. Owing to its rarity and difficulty in diagnosis, it is suggested that all such cases should be registered at national level and critically analyzed to find the high risk and associated prognostic factors.

Citing Articles

Clinicopathologic feature and treatment progress of high-grade ovarian neuroendocrine tumors.

He Q, Wang C, Huang D, Shen J, Liu R, Guan Y Med Oncol. 2024; 42(1):2.

PMID: 39541042 DOI: 10.1007/s12032-024-02544-w.

References
1.
Agarwal L, Gupta B, Jain A . Pure Large Cell Neuroendocrine Carcinoma of the Ovary with Metastasis to Cervix: A Rare Case Report and Review of Literature. J Clin Diagn Res. 2016; 10(9):ED01-ED03. PMC: 5071943. DOI: 10.7860/JCDR/2016/21639.8554. View

2.
Asada K, Kawana K, Teshima S, Saito A, Kawabata M, Fujii T . Poor prognosis of ovarian cancer with large cell neuroendocrine carcinoma: case report and review of published works. J Obstet Gynaecol Res. 2014; 40(3):869-72. DOI: 10.1111/jog.12235. View

3.
Yasuoka H, Tsujimoto M, Fujita S, Kunishige I, Nishio Y, Kodama R . Monoclonality of composite large cell neuroendocrine carcinoma and mucinous epithelial tumor of the ovary: a case study. Int J Gynecol Pathol. 2008; 28(1):55-8. DOI: 10.1097/PGP.0b013e31817fb419. View

4.
Shakuntala P, Uma Devi K, Shobha K, Bafna U, Geetashree M . Pure large cell neuroendocrine carcinoma of ovary: a rare clinical entity and review of literature. Case Rep Oncol Med. 2013; 2012:120727. PMC: 3523574. DOI: 10.1155/2012/120727. View

5.
Yang X, Chen J, Dong R . Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature. J Ovarian Res. 2019; 12(1):69. PMC: 6657379. DOI: 10.1186/s13048-019-0543-z. View